SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma.

Our findings demonstrated that SLC12A3 expression accounts for favorable prognosis and increased immune infiltration of various cell types. This could lead to potential therapeutic aims and biomarkers for KIRC (kidney renal clear cell carcinoma).

Authors

Fei Li (ORCID: https://orcid.org/0000-0002-0532-9054)
Qian Gao (ORCID: https://orcid.org/0000-0001-8189-6061)
Xia Ye (ORCID: https://orcid.org/0000-0001-6015-1634)

Publication Details

Journal: PubMed
Published: 2024-09-01
Citations: 2
Primary Topic: Renal cell carcinoma treatment
Type: article
Field-Weighted Citation Impact: 0.84

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma.

Fei Li, Qian Gao, Xia Ye

Sep 1, 2024

2 citations

PubMed

Renal cell carcinoma treatment

0.84

article

SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma.

Fei Li, Qian Gao, Xia Ye

September 1, 2024article en

2 citations

Abstract

PubMedVol. 30(9)

Good health and well-being

Openalex Percentile: Top 27%

Renal cell carcinoma treatment

0.84

OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SLC12A3: A Novel Prognostic Biomarker of Clear Cell Renal Cell Carcinoma. — Fei Li, Qian Gao, et al. · PubMed (2024) | TGRS Research Map | TGRS